The Impact of Pamidronate and Chemotherapy on Survival Times in Dogs with Appendicular Primary Bone Tumors Treated with Palliative Radiation Therapy

Veterinary Surgery

Volumn 41, Issue 3, 2012, Pages 430-435

  Oblak, Michelle L ^a   Boston, Sarah E ^a   Higginson, Geraldine ^a   Patten, Steven G ^a   Monteith, Gabrielle J ^a   Woods, J Paul ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID;

ANIMAL; ANIMAL DISEASE; ARTICLE; BONE TUMOR; DOG; DOG DISEASE; FEMALE; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; OSTEOSARCOMA; PALLIATIVE THERAPY; RETROSPECTIVE STUDY; SURVIVAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; COMBINED MODALITY THERAPY; DIPHOSPHONATES; DOG DISEASES; DOGS; FEMALE; MALE; OSTEOSARCOMA; PALLIATIVE CARE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84864997434     PISSN: 01613499     EISSN: 1532950X     Source Type: Journal    
DOI: 10.1111/j.1532-950X.2012.00968.x     Document Type: Article

References (34)

1. Liptak J, Dernell W, Ehrhart N, et al: Canine appendicular osteosarcoma: diagnosis and palliative treatment. Compend Cont Educ Pract Vet 2004;26:172-185
2. Coomer A, Farese J, Milner R, et al: Radiation therapy for canine appendicular osteosarcoma. Vet Comp Oncol 2009;7:15-27
3. Dernell WS, Straw RC, Withrow S: Tumors of the skeletal system, in Withrow SJ, MacEwen E (eds): Small animal oncology. Philidelphia, PA, WB Saunders, 2001, pp 378-417
4. Liptak JM, Dernell WS, Ehrhart N, et al: Canine appendicular osteosarcoma: curative-intent treatment. Compend Cont Educ Pract Vet 2004;26:186-196
5. Knapp-Hoch HM, Fidel JL, Sellon RK, et al: An expedited palliative radiation protocol for lytic or proliferative lesions of appendicular bone in dogs. J Am Anim Hosp Assoc 2009;45:24-32
6. McBride W, Withers H: Biologic basis of radiation therapy, in Halperin E, Perez C, Brady L (eds): Perez and Brady's principles and practice of radiation oncology (ed 5). Philadelphia, PA, Lippincott Williams & Wilkins, 2008, pp 76-108
7. Goblirsch MJ, Zwolak PP, Clohisy DR: Biology of bone cancer pain. Clin Cancer Res 2006;12:6231-6235
8. Mayer MN, Grier CK: Palliative radiation therapy for canine osteosarcoma. Can Vet J 2006;47:707-709
9. Goblirsch M, Mathews W, Lynch C, et al: Radiation treatment decreases bone cancer pain, osteolysis and tumor size. Radiat Res 2004;161:228-234
10. Ramirez O, Dodge RK, Page RL, et al: Palliative radiotherapy of appendicular osteosarcoma in 95 dogs. Vet Radiol Ultrasound 1999;40:517-522
11. Fan T: The role of bisphosphonates in the management of patients that have cancer. Vet Clin North Am Small Anim Pract 2007;37:1091-1110
12. Vassiliou V, Kardamakis D: The management of metastatic bone disease with the combination of bisphosphonates and radiotherapy: from theory to clinical practice. Anticancer Agents Med Chem 2009;9:326-335
13. Phillips B, Powers BE, Dernell WS, et al: Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs. J Am Anim Hosp Assoc 2009;45:33-38
14. Straw RC, Withrow SJ, Richter SL, et al: Amputation and cisplatin for treatment of canine osteosarcoma. J Vet Intern Med 1991;5:205-210
15. Thompson JP, Fugent MJ: Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990). J Am Anim Hosp Assoc 1992;200:531-533
16. Chun R, Garrett LD, Henry C, et al: Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma. J Am Anim Hosp Assoc 2005;41:382-387
17. Fan TM, Lorimier LPD, Garrett LD, et al: The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis. J Vet Intern Med 2008;22:380-387
18. Heidenreich A, Hofmann R, Engelmann U: The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer. J Urol 2001;165:136-140
19. Koeberle D, Bacchus L, Thuerlimann B: Pamidronate treatment in patients with malignant osteolytic bone disease and pain. Support Care Cancer 1999;7:21-27
20. Thrall DE: Textbook of veterinary diagnostic radiology. Philadelphia, PA, WB Saunders, 2002, pp 161-168
21. Wrigley R: Malignant versus nonmalignant bone disease. Vet Clin North Am Small Anim Pract 2000;30:315-347
22. Berzina I, Sharkey LC, Matise I, et al: Correlation between cytologic and histopathologic diagnoses of bone lesions in dogs: a study of the diagnostic accuracy of bone cytology. Vet Clin Path 2008;37:332-338
23. Britt T, Clifford C, Barger A, et al: Diagnosing appendicular osteosarcoma with ultrasound-guided fine-needle aspiration: 36 cases. J Sm An Pract 2007;48:145-150
24. Dodd LG, Scully SP, Cothran RL, et al: Utility of fine-needle aspiration in the diagnosis of primary osteosarcoma. Diagn Cytopathol 2002;27:350-353
25. Kerl ME: Update on canine and feline fungal diseases. Vet Clin North Am Small Anim Pract 2003;33:721-747
26. Wu JS-Y, Wong R, Johnston M, et al: Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 2003;55:594-605
27. Arcangeli G, Giovinazzo G, Saracino B, et al: Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys 1998;42:1119-1126
28. Kaasa S, Brenne E, Lund J-A, et al: Prospective randomised multicenter trial on single fraction radiotherapy (8Gyx1) versus multiple fractions (3Gyx10) in the treatment of painful bone metastases. Radiother Oncol 2006;79:278-284
29. Body JJ: Bisphosphonates for metastatic bone pain. Support Care Cancer 1999;7:1-3
30. Fan TM, Lorimier L-P de, O'Dell-Anderson K, et al: Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain. J Vet Intern Med 2007;21:431-439
31. Fan TM, Charney SC, Lorimier LP de, et al: Double-blind placebo-controlled trial of adjuvant pamidronate with palliative radiotherapy and intravenous doxorubicin for canine appendicular osteosarcoma bone pain. J Vet Intern Med 2009;23:152-160
32. Charney SC, Fan TM, Lorimier LP de, et al: Investigating the in vitro interactive effects of ionizing radiation and pamidronate in a canine osteosarcoma cell line. Vet Comp Oncol 2004;2:99-100
33. Major P, Lortholary A, Hon J, et al: Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol 2001;19:558-567
34. Rosen L, Gordon D, Dugan WJ, et al: Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion. Cancer 2004;100:36-43